# Vaccine Therapy in Treating Women With Metastatic Breast Cancer

> **NCT00003638** · PHASE3 · COMPLETED · sponsor: **Oncothyreon Canada Inc.** · enrollment: 950 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Detox-B adjuvant
- **BIOLOGICAL:** THERATOPE STn-KLH vaccine
- **BIOLOGICAL:** keyhole limpet hemocyanin
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT00003638
- **Lead sponsor:** Oncothyreon Canada Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2007-01
- **Final completion:** 2008-12
- **Target enrollment:** 950 (ESTIMATED)
- **Last updated:** 2013-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003638, "Vaccine Therapy in Treating Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00003638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*